Cancer Research

Insights

Browse:

Morning Administration of Cancer Immunotherapy May Help Patients Live Twice as Long

Curious Dr. George chats with Cancer Commons scientist Amanda Nottke, PhD, to explore the latest insights on this intriguing possibility.

How Would a Mayo Clinic Oncologist Manage His Own Mantle Cell Lymphoma?

Curious Dr. George speaks with Mayo Clinic oncologist Javier Munoz, MD, MS, MBA.

How Would a Mayo Clinic Oncologist Manage His Own Acute Lymphocytic Leukemia?

Curious Dr. George poses that question to leukemia expert Mark R. Litzow, MD.

New Device from Lungpacer Medical Helps Patients with Advanced Cancer

Curious Dr. George interviews Doug, president and CEO of Lungpacer Medical, about this novel approach.

High-Energy Blue Light Produced by Ultrasound Activates a Promising New Treatment, Sonodynamic Therapy, to Destroy Cancer Cells: An Update

Curious Dr. George spoke with Stuart L. Marcus, MD, PhD, founder and Chief Science Officer of SonALAsense.

How Would a Mayo Clinic Oncologist Manage His Own Chronic Lymphocytic Leukemia?

Curious Dr. George (George Lundberg, MD) posed the question to Mayo Clinic oncologist Sameer A. Parikh, MBBS.

Finding the Best Drug for a Specific Cancer: an Update on Travera

Curious Dr. George catches up with Dennis Watson, Vice President of Business Development, to learn how Travera’s services have progressed.

How Would a Harvard Oncologist Manage His Own Chronic Lymphocytic Leukemia?

Curious Dr. George chats with Harvard oncologist Jon Arnason, MD.

Brad Power, Cancer Hacker—Redesigning the Patient Experience

Curious Dr. George talks with Brad about his work.

Raising AI Right: Prioritizing Humanity in Precision Medicine

Curious Dr. George talks with our Director of Technology, Michael Kramer, about how Cancer Commons can help shape the future of AI in oncology.

How Would an Expert Manage His Own Chronic Myelogenous Leukemia?

Curious Dr. George poses the question to expert oncologist Jerald. Radich, MD, MA, MS.

A Better Way to Keep an Eye on Glioblastoma Tumors

Curious Dr. George chats with the company’s president and CEO, Michael Schmainda, about critical new advancements.

Keep in the loop

Get useful cancer research insights and updates

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

We never share you data with third parties.